Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7246-9. doi: 10.1016/j.bmcl.2010.10.101. Epub 2010 Oct 26.

Abstract

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One of these compounds was found to have good oral bioavailability and PK/PD profile in ZF-rat.

MeSH terms

  • Animals
  • Dipeptidyl Peptidase 4 / chemistry*
  • Dipeptidyl Peptidase 4 / metabolism
  • Dipeptidyl-Peptidase IV Inhibitors / chemical synthesis
  • Dipeptidyl-Peptidase IV Inhibitors / chemistry*
  • Dipeptidyl-Peptidase IV Inhibitors / pharmacokinetics
  • Drug Evaluation, Preclinical
  • Humans
  • Microsomes, Liver / metabolism
  • Piperidines / chemical synthesis
  • Piperidines / chemistry*
  • Piperidines / pharmacokinetics
  • Pyrimidinones / chemical synthesis
  • Pyrimidinones / chemistry*
  • Pyrimidinones / pharmacokinetics
  • Rats
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • (R)-3-amino-3-methylpiperidine
  • Dipeptidyl-Peptidase IV Inhibitors
  • Piperidines
  • Pyrimidinones
  • Dipeptidyl Peptidase 4